• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型神经纤维瘤病患儿的健康监督

Health Supervision for Children With Neurofibromatosis Type 1.

出版信息

Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2019-0660.

DOI:10.1542/peds.2019-0660
PMID:31010905
Abstract

Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system. Its population prevalence is approximately 1 in 3000. The condition is usually recognized in early childhood, when pigmentary manifestations emerge. Although NF1 is associated with marked clinical variability, most children affected follow patterns of growth and development within the normal range. Some features of NF1 can be present at birth, but most manifestations emerge with age, necessitating periodic monitoring to address ongoing health and developmental needs and minimize the risk of serious medical complications. In this report, we provide a review of the clinical criteria needed to establish a diagnosis, the inheritance pattern of NF1, its major clinical and developmental manifestations, and guidelines for monitoring and providing intervention to maximize the health and quality of life of a child affected.

摘要

神经纤维瘤病 1 型(NF1)是一种多系统疾病,主要涉及皮肤和周围神经系统。其人群患病率约为每 3000 人中有 1 人。这种疾病通常在儿童早期出现色素沉着表现时被识别出来。尽管 NF1 与明显的临床变异性相关,但大多数受影响的儿童的生长和发育模式都在正常范围内。NF1 的一些特征可能在出生时就存在,但大多数表现随着年龄的增长而出现,因此需要定期监测,以满足持续的健康和发育需求,并最大限度地降低严重医疗并发症的风险。在本报告中,我们回顾了建立诊断所需的临床标准、NF1 的遗传模式、其主要的临床和发育表现,以及监测和提供干预措施的指南,以最大限度地提高受影响儿童的健康和生活质量。

相似文献

1
Health Supervision for Children With Neurofibromatosis Type 1.1 型神经纤维瘤病患儿的健康监督
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2019-0660.
2
Health supervision for children with neurofibromatosis.神经纤维瘤病患儿的健康监督
Pediatrics. 2008 Mar;121(3):633-42. doi: 10.1542/peds.2007-3364.
3
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.小儿神经纤维瘤病 1 中的癌症和中枢神经系统肿瘤监测。
Clin Cancer Res. 2017 Jun 15;23(12):e46-e53. doi: 10.1158/1078-0432.CCR-17-0589.
4
[Neurofibromatosis type 1 or Von Recklinghausen's disease].1型神经纤维瘤病或冯·雷克林豪森病
Rev Med Interne. 2005 Mar;26(3):196-215. doi: 10.1016/j.revmed.2004.06.011.
5
Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.儿童和青少年1型神经纤维瘤病的心理社会特征
J Child Neurol. 2018 Mar;33(3):225-232. doi: 10.1177/0883073817749367. Epub 2018 Jan 10.
6
[Care recommendations for type 1 neurofibromatosis].[1型神经纤维瘤病的护理建议]
Acta Biomed Ateneo Parmense. 2000;71(3-4):83-7.
7
[Developmental manifestation in children with neurofibromatosis type 1].[1型神经纤维瘤病患儿的发育表现]
Harefuah. 2010 Jan;149(1):49-52, 61.
8
Neurofibromatosis type 1 (NF1): diagnosis and management.1型神经纤维瘤病(NF1):诊断与管理
Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9.
9
Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.使用美国国立卫生研究院标准诊断儿童1型神经纤维瘤病。
Pediatrics. 2000 Mar;105(3 Pt 1):608-14. doi: 10.1542/peds.105.3.608.
10
Neurofibromatosis type 1 system-based manifestations and treatments: a review.神经纤维瘤病 1 型系统表现及治疗:综述。
Neurol Sci. 2023 Jun;44(6):1931-1947. doi: 10.1007/s10072-023-06680-5. Epub 2023 Feb 24.

引用本文的文献

1
A Pediatric Case of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor of the Scalp.1例1型神经纤维瘤病相关的头皮恶性周围神经鞘膜瘤的儿科病例。
Plast Reconstr Surg Glob Open. 2025 Aug 1;13(8):e7024. doi: 10.1097/GOX.0000000000007024. eCollection 2025 Aug.
2
Selumetinib in Adult Neurofibromatosis 1 with Plexiform Neurofibroma.司美替尼治疗成人1型神经纤维瘤病合并丛状神经纤维瘤
Pharmaceuticals (Basel). 2025 Jul 13;18(7):1039. doi: 10.3390/ph18071039.
3
Case Report: Concurrent neurofibromatosis type 1 with papillary thyroid carcinoma and gastrointestinal stromal tumor.
病例报告:1型神经纤维瘤病合并甲状腺乳头状癌和胃肠道间质瘤。
Front Oncol. 2025 Jul 10;15:1529765. doi: 10.3389/fonc.2025.1529765. eCollection 2025.
4
Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases.加强初级保健中1型神经纤维瘤病的护理协调:罕见病的见解与应用
J Community Genet. 2025 Jul 3. doi: 10.1007/s12687-025-00811-5.
5
Beyond the Curve: Intra-spinal Rib Head Herniation as a Critical Complication of Dystrophic Scoliosis in Pediatric Patients With Neurofibromatosis Type 1.超越曲线:脊髓内肋骨小头疝作为1型神经纤维瘤病小儿患者营养不良性脊柱侧凸的关键并发症
Cureus. 2025 May 26;17(5):e84841. doi: 10.7759/cureus.84841. eCollection 2025 May.
6
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study.司美替尼治疗1型神经纤维瘤病成人患者及有症状、无法手术的丛状神经纤维瘤的疗效和安全性(KOMET):一项多中心、国际、随机、安慰剂对照、平行、双盲、3期研究
Lancet. 2025 Jun 21;405(10496):2217-2230. doi: 10.1016/S0140-6736(25)00986-9. Epub 2025 Jun 2.
7
Call for neurofibromatosis specialty care clinics in South Carolina.呼吁在南卡罗来纳州设立神经纤维瘤病专科护理诊所。
J Community Genet. 2025 May 31. doi: 10.1007/s12687-025-00803-5.
8
Clinical and epidemiological characterisation of neurofibromatosis type 1: Combined analysis of a reference hospital in Brazil and DataSUS.1型神经纤维瘤病的临床与流行病学特征:巴西一家参考医院与巴西统一卫生系统数据库的联合分析
Genet Mol Biol. 2025 Apr 25;48(1):e20240144. doi: 10.1590/1678-4685-GMB-2024-0144. eCollection 2025.
9
Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC.小儿肿瘤抑制基因突变的眼部表现:RB1、NF1、NF2、VHL和TSC的病例系列及文献综述
BMC Pediatr. 2025 May 10;25(1):371. doi: 10.1186/s12887-025-05694-6.
10
Recurrent Diffuse Neurofibroma of the Mandibular Anterior Lingual Alveolar Process Associated With Dental and Skeletal Changes in Neurofibromatosis Type 1.与1型神经纤维瘤病的牙齿和骨骼变化相关的下颌前舌侧牙槽突复发性弥漫性神经纤维瘤
Cancer Diagn Progn. 2025 May 3;5(3):330-343. doi: 10.21873/cdp.10445. eCollection 2025 May-Jun.